A61K 38/177
Receptors
Official title: {Receptors; Cell surface antigens; Cell surface determinants}
A61K38/177 (Receptors) appears on 3,099 US grants and 6,421 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,099
- Published applications
- 6,421
- Assignees
- 2,101
- Inventors
- 9,689
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 13 | 0 |
| 1999 | 6 | 0 |
| 2000 | 12 | 0 |
| 2001 | 18 | 18 |
| 2002 | 28 | 81 |
| 2003 | 22 | 97 |
| 2004 | 13 | 111 |
| 2005 | 16 | 109 |
| 2006 | 29 | 115 |
| 2007 | 42 | 129 |
| 2008 | 42 | 120 |
| 2009 | 45 | 148 |
| 2010 | 81 | 154 |
| 2011 | 72 | 170 |
| 2012 | 82 | 171 |
| 2013 | 82 | 209 |
| 2014 | 127 | 244 |
| 2015 | 143 | 288 |
| 2016 | 163 | 348 |
| 2017 | 201 | 312 |
| 2018 | 184 | 426 |
| 2019 | 237 | 417 |
| 2020 | 234 | 385 |
| 2021 | 232 | 504 |
| 2022 | 230 | 501 |
| 2023 | 184 | 424 |
| 2024 | 203 | 366 |
| 2025 | 190 | 325 |
| 2026 | 157 | 249 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions, methods and kits for treating complement related disorders6 Oct 2026US 12,751,993 B2Trustees of Tufts College
- Methods of reducing neuroinflammation6 Oct 2026US 12,751,994 B2ImmunityBio, Inc.
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- Method of treatment of cancer or tumour29 Sep 2026US 12,746,272 B2
- CD5 chimeric antigen receptor for adoptive T cell therapy29 Sep 2026US 12,746,273 B2Baylor College of Medicine
- Methods of decreasing pathological neuroinflammation8 Oct 2026US 2026/0306585 A1Washington University
- Materials and methods for increasing immune responses within a mammal8 Oct 2026US 2026/0306668 A1Mayo Foundation for Medical Education and Research
- Composition comprising an antibody which binds to human srrm2 present on the cell surface of a target cell8 Oct 2026US 2026/0308237 A1Eximmium Biotechnologies GmbH
- Gene therapy8 Oct 2026US 2026/0308598 A1
- Therapeutic circular dna forms1 Oct 2026US 2026/0294957 A1Flagship Pioneering Innovations Vii, LLC
Most cited
By later US patents
- Methods for treatment of cancer368US 8,906,682 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof353US 8,278,036 B2The Trustees of the University of Pennsylvania · 2012
- Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1328US 7,595,048 B2Ono Pharmaceutical Co., Ltd. · 2009
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Compositions for treatment of cancer277US 8,911,993 B2The Trustees of the University of Pennsylvania · 2014